FIELD: medicine.
SUBSTANCE: invention can be used to assess a risk of cervical cancer accompanying cervical intraepithelial neoplasia and a human papilloma virus (HPV) carrier state in fertile females. That is ensured by sampling cells from the exocervical surface to recover RNA and measuring the gene mRNA expression levels: MKI67, CDKN2A, PGR, BAX. Relating the mRNA expression levels provides calculating a linear discriminant function (LDF): LDF=1.2*lg[CDKN2A]/[BAX]-lg[PGR]/[MKI67]-1, wherein [CDKN2A]/[BAX] is the relation of the CDKN2A and BAX mRNA expression levels, [PGR]/[MKI67] is the relation of the progesterone receptor and MKI67 mRNA expression levels, and if LDF≤0, a low risk of neoplastic transformation is stated; LDF>0 shows a higher risk of neoplastic transformation.
EFFECT: method enables assessing a risk of cervical cancer by the representation of reference genes mRNAs.
2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
METHOD FOR CERVICAL CARCINOGENESIS DETECTION | 2015 |
|
RU2702334C2 |
METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER | 2012 |
|
RU2538618C2 |
METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
METHOD FOR DIFFERENTIATION OF CERVICAL INTRAEPITHELIAL NEOPLASIAS BY ANALYZING THE PROTEOMIC COMPOSITION OF CERVICOVAGINAL FLUID | 2017 |
|
RU2674335C1 |
3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
Authors
Dates
2014-11-10—Published
2012-04-11—Filed